Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – The morbidity of extensive axillary lymph node dissection can be avoided without jeopardizing survival for some breast cancer patients with positive sentinel lymph…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – An interval of no more than 14 days between ultrasonograms in monochorionic twins appears to increase detection of twin-to-twin transfusion syndrome (TTTS), researchers…
NEW YORK (Reuters Health) – For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a…
NEW YORK (Reuters Health) – Women with polycystic ovary syndrome have increased levels of LDL-cholesterol and non-HDL-cholesterol, as well as more widely recognized alterations in triglycerides and HDL…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) is not helpful in the treatment of women with unexplained recurrent miscarriage and, for now, should not be used outside…
NEW YORK (Reuters Health) – In a small study of pregnant women with type 1 diabetes, use of a closed-loop insulin delivery system (also known as the artificial…
